Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals exhibits a capital structure with total liabilities of ₹605.3 crore and total equity of ₹593.2 crore, yielding a debt-to-equity ratio of 0.66. The company holds only ₹1.3 crore in cash and equivalents, while long-term debt stands at ₹389.7 crore, creating a net cash deficit of ₹388.4 crore. The current ratio of 0.78 indicates liquidity stress, with current liabilities exceeding current assets. Profitability metrics show significant underperformance: return on equity of -18.17% and return on assets of -8.99%, both well below the industry median for pharmaceutical firms. Operating income of -₹151.4 crore and net income of -₹107.8 crore reflect a deteriorating operating margin, which is a critical concern for a company in a capital-intensive sector. The company operates through a single segment, Bulk Drugs and Intermediates, with no disclosed geographic revenue breakdown. This lack of diversification increases exposure to regional demand shifts and regulatory changes in India. The absence of segmental or geographic data limits visibility into potential growth vectors. Growth trajectory is negative, with no disclosed revenue growth rates or forward-looking guidance. The company reported a revenue of ₹194.5 crore in the latest period, but operating cash flow of -₹139.9 crore and free cash flow of -₹235.5 crore suggest operational inefficiencies. Capital expenditures of -₹124.8 crore further indicate a lack of investment in growth infrastructure. Risk factors include medium liquidity risk due to negative net cash and a current ratio below 1. The risk assessment flags a net cash deficit after subtracting total debt, which could constrain operational flexibility. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. However, the company's negative operating cash flow and high debt load could necessitate future capital raises. Recent filings and transcripts are not disclosed in the input data, but the financial snapshot indicates a deteriorating operating performance. The company's negative net income and operating cash flow suggest potential challenges in maintaining operations without external financing. No recent events are cited in the input data to explain this performance.